Abstract
In this study, we sought to compare protein concentrations obtained from a high-throughput proteomics platform (Olink) on samples collected using capillary blood self-collection (with the Tasso+ device) versus standard venipuncture (control). Blood collection was performed on 20 volunteers, including one sample obtained via venipuncture and two via capillary blood using the Tasso+ device. Tasso+ samples were stored at 2°C–8°C for 24-hs (Tasso-24) or 48-h (Tasso-48) prior to processing to simulate shipping times from a study participant’s home. Proteomics were analyzed using Olink (384 Inflammatory Panel). Tasso+ blood collection was successful in 37/40 attempts. Of 230 proteins included in our analysis, Pearson correlations (r) and mean coefficient of variation (CV) between Tasso-24 or Tasso-48 versus venipuncture were variable. In the Tasso-24 analysis, 34 proteins (14.8%) had both a correlation r > 0.5 and CV < 0.20. In the Tasso-48 analysis, 68 proteins (29.6%) had a correlation r > 0.5 and CV < 0.20. Combining the Tasso-24 and Tasso-48 analyses, 26 (11.3%) proteins met these thresholds. We concluded that protein concentrations from Tasso+ samples processed 24–48 h after collection demonstrated wide technical variability and variable correlation with a venipuncture gold-standard. Use of home capillary blood self-collection for large-scale proteomics should be limited to select proteins with good agreement with venipuncture.
Keywords: blood proteins, blood specimen collection, proteomics, tasso
1 |. INTRODUCTION
Capillary blood self-collection provides advantages in patient convenience, accessibility, and comfort as compared to conventional venipuncture-based methods [1]. With the increased use of telehealth during the Covid-19 pandemic, there has been renewed interest in the use of capillary blood self-collection to facilitate blood sampling from patients’ homes. Currently, multiple self-collection devices are now available, and initial studies have shown encouraging results with good agreement with conventional venipuncture for the measurement of various analytes [1–3]. However, a limiting factor for the widespread use of these devices is that the concordance between venous and capillary samples collected by self-sampling devices varies across analytes and depends on factors such as pre-analytical conditions, processing delay, and measurement technique [3, 4]. Nevertheless, the accessibility and ease of these devices have the potential to transform blood collection practices in scenarios where conventional blood draws at health-care facilities may be challenging.
Given the utility of high-throughput proteomics to provide insight into pathophysiology and enable biomarker discovery [5], the use of capillary blood self-collection techniques has the potential to increase diversity and sample availability for discovery studies. However, the application of capillary blood self-collection devices for large-scale proteomics has been largely unexplored and the agreement in protein concentrations detected from these samples as compared to conventional venipuncture remains unknown. In this pilot study, we sought to compare protein concentrations obtained from a high-throughput proteomics platform (Olink) on samples collected using capillary blood self-collection (with the Tasso+ device) versus standard venipuncture (control).
2 |. MATERIALS AND METHODS
This study was approved by the Vanderbilt University Medical Center Institutional Review Board. Twenty healthy volunteers were recruited at the study site and included in this pilot study after providing informed consent. Volunteers were asked to provide three blood samples, including one venipuncture sample collected in an EDTA tube (10 mL BD Vacutainer with K2 EDTA, BD Diagnostics, New Jersey, United States) by a certified phlebotomist and two self-collected capillary blood samples obtained using the Tasso+ device (Tasso Inc, Washington, United States). The venipuncture samples were immediately placed on ice in a cooler and then transported to the lab where they were placed in a fridge at 4°C. Centrifugation was then performed (3000 × g for 15 min at 4°C) with prompt aliquoting and storage at −80°C thereafter. The mean time of venipuncture blood collection to centrifugation was 256 ± /−105 min.
Tasso + device blood collections were performed per the manufacturer’s instructions into a BD Microtainer Tube with K2 EDTA (BD Diagnostics). In brief, participants applied a heating pad to the skin of the upper lateral arm for 2 min. This site was then sterilized with an alcohol wipe before attaching the device to the skin of a shoulder. The device was removed after either ≥500 μL of blood was collected in the microtainer or 5 min passed from initial device placement. If the volunteer required or asked for assistance using the device, this was provided by study staff. These steps were then repeated on the opposite shoulder using a second device. The first blood sample collected by a Tasso+ device was used as Tasso-24 and the second sample was used as Tasso-48. If only one of the two attempts was successful, this sample was used as the Tasso-24 sample. An unsuccessful Tasso blood collection attempt was defined as the failure to collect any blood. The Tasso+ samples were stored in Nanocool packs (Peli Biothermal, Minnesota, United States) at 2°C–8°C immediately after collection, including one for approximately 24 h (Tasso-24) and one for approximately 48 h (Tasso-48), prior to lab processing to simulate shipping times from remote patient locations. Centrifugation was performed with the same speed and duration for Tasso+ samples as venipuncture samples.
2.1 |. Proteomic analysis
We measured 384 proteins involved in inflammation in each plasma sample using a next-generation sequencing-based Olink platform (Explore 384 Inflammation Panel; Olink, Sweden) that provides relative protein concentration. We selected a panel of 384 proteins to include a wide range of analytes and this significantly exceeds prior studies examining capillary blood self-collection [2, 3]. The inflammatory panel was specifically chosen because we hypothesized that proteins involved in inflammation would be the most likely to have alterations in concentrations because of changes in blood collection technique and storage that could lead to cell lysis or clumping, and therefore, may better determine whether large scale proteomics for the purpose of discovery would be feasible using Tasso+. No samples were excluded due to technical failure of proteomics. To assess technical variability, we included two aliquots from a pooled plasma sample (a mixture of all study samples) in the run. These measurements were then used to calculate CV. We removed 20 proteins with expressions below the limit of detection in 25% or more of all samples. Then we excluded an additional 118 proteins that had significant technical variation, defined by coefficient of variation (CV) greater than the mean, in control samples. This left 230 proteins to be used in the analysis.
2.2 |. Statistical design
To measure the degree of agreement between Tasso samples and venipuncture, we calculated the CVs of Tasso-24 versus venipuncture and Tasso-48 versus venipuncture. We then performed Pearson correlations between Tasso-24 versus venipuncture and Tasso-48 versus venipuncture. We repeated the CV and correlation analyses between Tasso-24 and Tasso-48 to determine the agreement of samples with different storage times. To evaluate potential differences in agreement between cytokines/chemokines and other plasma proteins, we stratified our analyses based on whether each protein was categorized as an established cytokine or chemokine. CVs and correlations were run using linear normalized protein expression (NPX) values (2NPX). In addition, Bland–Altman plots were presented in select proteins with a high or low degree of agreement. An acceptable level of agreement was defined as Pearson correlation coefficient r ≥ 0.5 and CV ≤ 0.20. Although these are arbitrary cut-points, we used Pearson r of 0.5 because this would signify a moderate to strong correlation and we had adequate power to detect a minimum correlation of 0.49 with our sample size of 40 (20 in each group) with alpha of 5% and 90% power. CV of 20% has been used as upper-bound for an acceptable level of agreement in other studies [6–8]. All statistical analyses were performed with the R software version (4.0.5).
3 |. RESULTS
Twenty volunteers were included in this study (nine females; mean age 36 +/− 11.3 years). Tasso+ blood draw was successful in 37/40 attempts (92.5%), yielding 20 Tasso-24 samples and 17 Tasso-48 samples. The three unsuccessful samples were due to the absence of any blood collected by the Tasso+ device. The mean blood volume of samples collected was 410 +/− 134 μL.
Our first step was to evaluate the mean CVs between Tasso-24 versus venipuncture and Tasso-48 versus venipuncture for the 230 proteins included in the analysis (Figure 1A, C). We observed a wide range of mean CVs among individual proteins (Tasso-24 vs. venipuncture, median = 0.260 [25th–75th percentile: 0.158–0.429]; Tasso-48 versus venipuncture, median = 0.229 [25th–75th percentile: 0.123–0.464]). In total, 87/230 (37.8%) proteins had a mean CV ≤ 0.20 in the Tasso-24 group and 97/230 (42.2%) in the Tasso-48 group as compared to venipuncture. The range of mean CVs in the Tasso-24 versus Tasso-48 analysis was also wide (median = 0.172 [25th–75th percentile: 0.112–0.294]) and 129/230 proteins (56.1%) had mean CVs < 0.20. Bland–Altman plots for the three proteins with the lowest and highest mean CVs from the Tasso-24 versus venipuncture analysis are shown in Figure 2. While Bland–Altman plots for most proteins did not visually demonstrate a strong correlation between venipuncture concentration and the difference measured from Tasso samples, several demonstrated strong negative correlations, including DAPP1 (Figure 2E), DECR1, GOPC, PLXNA4, PLA2G4A, DAG1, and CLIP2 (Figure S1), among others.
FIGURE 1.

(Panel A) Histogram with density curve showing the distribution of CV of proteins (N = 230) between Tasso-24 and conventional venipuncture. (Panel B) Histogram with density curve showing the distribution of Pearson r of proteins between Tasso-24 and conventional venipuncture. (Panel C) Histogram with density curve showing the distribution of CV of proteins between Tasso-48 and conventional venipuncture. (Panel D) Histogram with density curve showing the distribution of Pearson r of proteins between Tasso-48 and conventional venipuncture. The red dotted line in Panels A and D indicates a CV of 5% and the blue dotted line indicates a CV of 20%.
FIGURE 2.

Bland–Altman plots with venipuncture concentration on the x-axis and difference between Tasso-24 and venipuncture on the y-axis. The blue line indicates the mean difference between venipuncture and Tasso-24. The red lines indicate the upper or lower limit of the 95% confidence interval for the difference between venipuncture and Tasso-24. Values are shown in linear NPX values (2NPX). Scales for each panel are different. Panels A–C include the three proteins with the lowest coefficient of variation (CV) between Tasso-24 and venipuncture. All proteins had minimal mean differences with low variance. Panels D–F includes the three proteins with the highest CV between Tasso-24 and venipuncture. These proteins had large mean differences and wide variance. Notably, DAPP1 (Panel E) had a strong trend of greater negative differences with Tasso-24 observed with higher venipuncture concentrations.
Next, we evaluated Pearson correlations for individual proteins for the Tasso+ versus venipuncture samples (Figure 1B,D). Correlations were highly variable between Tasso-24 and venipuncture samples (median = 0.187 [25th–75th percentile: −0.110–0.513]), and 61/230 proteins (26.5%) had correlations that were considered acceptable (r ≥ 0.5). Results for the Tasso-48 versus venipuncture analysis were largely similar, with a wide range of correlation (median = 0.396 [25th–75th percentile: 0.068–0.702]); 99/230 proteins (43.0%) exhibited an r ≥ 0.5. In the Tasso-24 versus Tasso-48 analysis, the range of Pearson r remained wide (median = 0.538 [25th–75th percentile: 0.329–0.701]) and 122/230 proteins (53.0%) had r > 0.5.
Then, we evaluated the relationship between CV and Pearson r for each protein in both Tasso versus venipuncture analyses (Figure 3). We observed that proteins with a high degree of variance mostly had weak correlations. When the Pearson r and mean CV for each protein in the Tasso-24 versus venipuncture analysis were combined, 34 proteins (14.8%) had both correlations r ≥ 0.5 and low variation (mean CV ≤ 0.20; Table 1). In the Tasso-48 versus venipuncture analysis, 68 proteins (29.6%) had both correlations r ≥ 0.5 and low variation (mean CV ≤ 0.20). There were 26 proteins that met the criteria for these correlations and mean CV thresholds in both the Tasso-24 and Tasso-48 versus venipuncture analyses. Of these, 23/26 (88.4%) proteins also had both correlations r ≥ 0.5 and mean CV ≤ 0.20 in the Tasso-24 versus Tasso-48 analyses further suggesting stability with either storage time. These 26 proteins, as well as their CV and correlation coefficients, are listed in Table 2.
FIGURE 3.

(Panel A) Scatterplot showing the relationship of Pearson r and CV of proteins between Tasso-24 and conventional venipuncture. (Panel B) Scatterplot showing the relationship of Pearson r and CV of proteins between Tasso-48 and conventional venipuncture.
TABLE 1.
Number of proteins in each analysis stratified by Pearson r and mean CV.
| Pearson r ≥ 0.5 | Pearson r < 0.5 | |
|---|---|---|
| Tasso-24 versus venipuncture | ||
| Mean CV ≤ 0.2 | 34 | 53 |
| Mean CV > 0.2 | 27 | 116 |
| Tasso-48 versus venipuncture | ||
| Mean CV ≤ 0.2 | 68 | 29 |
| Mean CV > 0.2 | 31 | 102 |
| Tasso-24 versus Tasso-48 | ||
| Mean CV ≤ 0.2 | 84 | 45 |
| Mean CV > 0.2 | 38 | 63 |
Abbreviation: CV, coefficient of variation.
TABLE 2.
List of 26 proteins that had Pearson correlation r ≥ 0.5 and CV ≤ 0.20 for both Tasso-24 and Tasso-48 analyses as compared to conventional venipuncture.
| Tasso-24 versus Venipuncture |
Tasso-48 versus Venipuncture |
Tasso-24 versus Tasso-48 |
||||
|---|---|---|---|---|---|---|
| Protein | Mean CV | Pearson r | Mean CV | Pearson r | Mean CV | Pearson r |
| ADGRE2 | 0.128 | 0.606 | 0.111 | 0.618 | 0.108 | 0.564 |
| CCL25 | 0.142 | 0.664 | 0.123 | 0.703 | 0.140 | 0.684 |
| CDON | 0.122 | 0.633 | 0.078 | 0.793 | 0.059 | 0.891 |
| DNER | 0.091 | 0.530 | 0.060 | 0.781 | 0.058 | 0.856 |
| EPHA1 | 0.139 | 0.672 | 0.116 | 0.823 | 0.049 | 0.953 |
| FCRL2 | 0.156 | 0.735 | 0.111 | 0.946 | 0.090 | 0.950 |
| IFNLR1 | 0.123 | 0.608 | 0.123 | 0.700 | 0.100 | 0.841 |
| IL4R | 0.117 | 0.572 | 0.105 | 0.769 | 0.422 | 0.142 |
| IL5RA | 0.133 | 0.680 | 0.189 | 0.515 | 0.167 | 0.663 |
| IL10RA | 0.162 | 0.999 | 0.184 | 0.999 | 0.218 | 0.999 |
| ISM1 | 0.147 | 0.587 | 0.161 | 0.754 | 0.129 | 0.659 |
| KYNU | 0.194 | 0.514 | 0.176 | 0.656 | 0.147 | 0.776 |
| LAMP3 | 0.173 | 0.607 | 0.121 | 0.841 | 0.095 | 0.846 |
| LTA | 0.075 | 0.788 | 0.121 | 0.635 | 0.121 | 0.684 |
| LTBR | 0.100 | 0.582 | 0.099 | 0.585 | 0.113 | 0.282 |
| LY9 | 0.089 | 0.648 | 0.069 | 0.883 | 0.074 | 0.806 |
| MATN2 | 0.114 | 0.794 | 0.103 | 0.867 | 0.090 | 0.845 |
| MERTK | 0.114 | 0.631 | 0.095 | 0.909 | 0.085 | 0.770 |
| NCR1 | 0.114 | 0.725 | 0.140 | 0.653 | 0.097 | 0.776 |
| NFASC | 0.090 | 0.701 | 0.097 | 0.678 | 0.099 | 0.717 |
| OSCAR | 0.162 | 0.552 | 0.104 | 0.673 | 0.077 | 0.920 |
| PON3 | 0.112 | 0.590 | 0.093 | 0.651 | 0.101 | 0.706 |
| TNFRSF11A | 0.135 | 0.599 | 0.091 | 0.813 | 0.138 | 0.500 |
| TNFRSF11B | 0.161 | 0.675 | 0.102 | 0.886 | 0.113 | 0.811 |
| TREM2 | 0.177 | 0.832 | 0.105 | 0.969 | 0.151 | 0.837 |
| VEGFD | 0.184 | 0.514 | 0.120 | 0.781 | 0.133 | 0.808 |
Abbreviation: CV, coefficient of variation.
In assessing protein concentrations between Tasso and venipuncture samples for cytokines and chemokines in comparison to other plasma proteins, we stratified the agreement analysis focusing on established cytokines/chemokines (33 out of 230 proteins; Supplemental Data). We identified a wide range in mean CV for cytokines/chemokines (median 0.320 [25th–75th percentile: 0.189–0.427] for venipuncture vs. Tasso-24; median 0.258 [25th–75th percentile: 0.172–0.399] for venipuncture vs. Tasso-48). This was consistent with the wide variation observed with non-cytokine/chemokine proteins (median 0.250 [25th–75th percentile: 0.155–0.432] for venipuncture vs. Tasso-24; median 0.228 [25th–75th percentile: 0.121–0.472] for venipuncture vs. Tasso-48). Range in Pearson correlations of cytokines/chemokines was also wide (median 0.125 [25th–75th percentile: 0.029–0.463] for venipuncture vs. Tasso-24; median 0.440 [25th–75th percentile: 0.141–0.743] for venipuncture versus Tasso-48) and was consistent with the wide range observed with non-cytokine/chemokine proteins (median 0.202 [25th–75th percentile: −0.121–0.516] for venipuncture vs. Tasso-24; 0.368 [25th–75th percentile: 0.066–0.682] for venipuncture vs. Tasso-48).
4 |. DISCUSSION
The principal findings of our study are four-fold. First, capillary blood collection using the Tasso+ device was successful in providing analyzable samples in 92.5% of attempts, suggesting its utility for in-home collection of venous blood. Second, CVs of individual proteins widely varied between Tasso and venipuncture samples, with the pattern of variation not dependent on the length of storage time before lab processing of Tasso samples (24 vs. 48 h). Pearson correlations similarly demonstrated a wide range with no improvement in Tasso samples that were stored for 24 h as opposed to 48 h. Finally, a minority of proteins (11.3%) had a high correlation and low variation in Tasso samples under both storage conditions. Collectively, these findings suggest that remote capillary blood self-collection with 24- or 48-h shipping prior to processing at a lab is currently likely not a suitable method for large-scale plasma proteomic discovery but is likely useful for the measurement of limited analytes that demonstrate good agreement with venipuncture.
In clinical practice, the need to perform blood collection at healthcare facilities by trained phlebotomists is a significant barrier to expanding applications of telemedicine to improve patient access [9]. In large-scale research studies, in-person collection can decrease participant diversity and limit sample availability to those who are in close geographic proximity to blood collection sites and have reliable means of transportation. These limitations of venipuncture-based blood collection became considerably more problematic during the Covid pandemic. Microneedle-based devices for blood collection are simple to use and obviate the need to obtain blood at specialized healthcare centers [1–3]. Additionally, studies using these devices, including Tasso+, have reported high success rates with minimal training as well as improved pain and patient satisfaction as compared to conventional venipuncture [1, 4, 10, 11]. If proven to provide concordant lab results as venipuncture for analytes of interest, these devices have the potential to dramatically improve blood sampling practices in scenarios where venipuncture-based methods are challenging.
Various different applications for home blood collection devices have been studied with most demonstrating good agreement with venipuncture for a wide range of analytes, including Covid serologies [3, 12, 13], hemoglobin A1C [1, 14], various chemistry labs (creatinine, glucose, magnesium, bilirubin, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase) [3, 15], tacrolimus and cyclosporin levels [16], uracil [17], HIV pre-exposure prophylaxis monitoring [10], and athlete biological passport analyses [18]. Despite these largely encouraging results, the concordance of capillary blood self-collection as compared to conventional venipuncture remains dependent on the analyte measured and inherent differences in collection site (e.g., venous as opposed to capillary blood) and pre-analytical conditions. For example, one study evaluating the agreement between Tasso SST (prior generation device) with immediate on-site processing and conventional venipuncture for 17 protein inflammatory biomarkers reported good correlations with little sample type bias for the majority of proteins, including CRP, Ferritin, IL-6, PCT, and others, but no correlation for some, including D-dimer, IL-1B, and IL-1Ra [4]. However, when comparing Tasso SST samples obtained in the clinic with prompt specimen processing to those with self-collection at home and delayed processing, levels of several proteins (including IL-1Ra, IL-5, IL-6Ra, LCN, PCT, D-dimer, and IL-1B) were significantly different between patients from the two protocols, suggesting that temperature during storage and transit times may alter some protein concentrations.
A key difference between most of these studies and our current study likely to account at least in part for our results is the critical nature of “omics” based analyses: we tested the agreement of samples that had delayed processing after 24- and 48-h of storage at 2°C–8°C to simulate shipping conditions from patients’ homes. For proteomics (or other assays that have cellular and circulating compartments), cellular lysis or microthrombosis during collection or this storage time may produce significant alterations in the expression, metabolism, or release of proteins. Indeed, several proteins exhibited strong negative correlations between their concentrations in venipuncture samples and the differences measured from Tasso samples. This suggests that protein degradation in the Tasso samples may be a contributing factor in some of the observed differences in protein concentrations between the two sample types. Immediate processing of onsite blood using the Tasso+ device may be preferred in these cases, to limit the confounding effects of these pre-analytical factors. Of note, shorter storage time (24 as opposed to 48 h) did not lead to improved correlations or variance as compared to venipuncture in our study. In fact, the 48-h samples had a greater number of proteins that met the threshold for acceptable correlation and CV with venipuncture as compared to the 24-h samples (68 vs. 34). Given the overall high variation in both analyses and lack of a biological plausible reason for improved agreement with longer storage, this finding may have occurred by chance.
To our knowledge, this is the first study comparing capillary and venous blood for proteomics using the Olink platform. Nevertheless, our study has several key limitations. First, we used the Olink 384 Inflammatory Panel, which may have been more susceptible to the effects of pre-analytical dwell time before plasma isolation. The agreement of other proteomic panels including non-inflammatory proteins may have different results. This study also included a limited sample size including a healthy population that likely had relatively low levels of circulating inflammatory proteins at baseline. Moreover, Tasso+ blood collections were supervised, and assistance was provided when needed. Home self-collection by patients may negatively impact the success and quality of the sample obtained. Nevertheless, multiple other studies have demonstrated high success rates of unsupervised self-collection [1, 2, 10]. Last, the mean time from venipuncture blood collection to centrifugation was relatively large in this study. However, it is unlikely that this would have significantly altered our main findings, as any delay in centrifugation of the venipuncture samples (which were performed same day) would only reduce the difference in pre-processing storage time compared to Tasso samples (which were processed at 24 or 48 h). The wide technical variability and variable correlations between the Venipuncture and Tasso samples would not be expected to improve with greater differences in pre-processing storage time.
Discovery proteomics relies on the accurate detection of relative or absolute protein concentrations involving thousands of proteins [19]. In our study, most proteins analyzed from capillary blood self-collection did not demonstrate acceptable correlations and variation with conventional venipuncture. Our findings highlight limitations in the use of home collection devices for proteomics, though the use of select clinical or discovery assays for proteins more robust to dwell pre-plasma isolation and other pre-analytical factors cannot be excluded. Given that some proteins in this analysis consistently demonstrated acceptable agreement with venipuncture, there may be a role for capillary blood self-collection to improve blood sampling practices in analyses involving selected proteins with good agreement with venipuncture.
Supplementary Material
Significance of the Study.
Capillary blood self-collection provides advantages in patient convenience, accessibility, and comfort as compared to conventional venipuncture-based methods. Currently, multiple self-collection devices are now available, and initial studies have shown encouraging results with good agreement with conventional venipuncture for the measurement of various analytes. However, the use of capillary blood self-collection devices to improve patient accessibility and diversity for large-scale proteomics has been largely unexplored and the agreement in protein concentrations detected from these samples as compared to conventional venipuncture is unknown. In this pilot study, we found wide technical variation and variable correlation of capillary blood self-collection with delayed sample processing (24 or 48 h) as compared to a venipuncture gold standard. A minority of proteins (11.3%) had high correlation (r > 0.5) and low variation (CV < 0.20) in Tasso samples irrespective of sample pre-processing storage time. These findings suggest that remote capillary blood self-collection with 24 or 48 h shipping prior to processing at a lab is likely not a suitable method for large-scale plasma proteomic discovery but may be useful for measurement of limited analytes that demonstrate good agreement with venipuncture.
ACKNOWLEDGMENTS
Tasso provided approximately half of the device kits used in this study at no charge. They had no role in study design, analysis, or reporting. No other funding was received for this study.
Abbreviation:
- CV
coefficient of variation
Footnotes
CONFLICT OF INTEREST STATEMENT
Bassim El-Sabawi is supported by T32 HG008341. Brian R. Lindman is supported by R01HL164526 and R01AG073633 and has received investigator-initiated research grants and consulted for Edwards Life-sciences. Ravi Shah is supported in part by grants from the National Institutes of Health and the American Heart Association. In the past 12 months, Ravi Shah has served as a consultant for Amgen and Cytokinetics. Ravi Shah is a co-inventor on a patent for ex-RNAs signatures of cardiac remodeling and a pending patent on proteomic signatures of fitness and lung and liver diseases.
SUPPORTING INFORMATION
Additional supporting information may be found online https://doi.org/10.1002/pmic.202300607 in the Supporting Information section at the end of the article.
DATA AVAILABILITY STATEMENT
The data that supports the findings of this study are available in the supplementary material of this article.
REFERENCES
- 1.Blicharz TM, Gong P, Bunner BM, Chu LL, Leonard KM, Wakefield JA, Williams RE, Dadgar M, Tagliabue CA, El Khaja R, Marlin SL, Haghgooie R, Davis SP, Chickering DE, & Bernstein H (2018). Microneedle-based device for the one-step painless collection of capillary blood samples. Nature Biomedical Engineering, 2, 151–157. [DOI] [PubMed] [Google Scholar]
- 2.Ansari S, Abdel-Malek M, Kenkre J, Choudhury SM, Barnes S, Misra S, Tan T, & Cegla J (2021). The use of whole blood capillary samples to measure 15 analytes for a home-collect biochemistry service during the SARS-CoV-2 pandemic: A proposed model from North West London Pathology. Annals of Clinical Biochemistry, 58, 411–421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hosseini B, Dasari H, Smyrnova A, Bourassa C, Leng J, Renaud C, & Ducharme FM (2023). Concordance in COVID-19 serology, bone mineralization, and inflammatory analytes between venous and self-collected capillary blood samples exposed to various pre-analytical conditions. Annals of Clinical Biochemistry, 60, 259–269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Brandsma J, Chenoweth JG, Gregory MK, Krishnan S, Blair PW, Striegel DA, Mehta R, Schully KL, Dumler JS, Sikorski CCS, O’Connor K, Reichert-Scrivner SA, Paguirigan CM, Uyehara CFT, Ngauy CV, Myers CA, & Clark DV (2022). Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients. PLoS ONE, 17, e0272572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Cui M, Cheng C, & Zhang L (2022). High-throughput proteomics: A methodological mini-review. Laboratory Investigation, 102, 1170–1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Huang R, Jiang W, Yang J, Mao YQ, Zhang Y, Yang W, Yang D, Burkholder B, Huang RF, & Huang RP (2010). A biotin label-based antibody array for high-content profiling of protein expression. Cancer Genomics & Proteomics, 7, 129–141. [PubMed] [Google Scholar]
- 7.Mörtstedt H, Kåredal MH, Jönsson BA, & Lindh CH (2013). Screening method using selected reaction monitoring for targeted proteomics studies of nasal lavage fluid. Journal of Proteome Research, 12, 234–247. [DOI] [PubMed] [Google Scholar]
- 8.Zhang J, Yang S, Wang J, Xu Y, Zhao H, Lei J, Zhou Y, Chen Y, Wu L, & Li Y (2023). Equivalent carbon number-based targeted odd-chain fatty acyl lipidomics reveals triacylglycerol profiling in clinical colon cancer. Journal of Lipid Research, 64, 100393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Sun CA, Shenk Z, Renda S, Maruthur N, Zheng S, Perrin N, Levin S, & Han HR (2023). Experiences and perceptions of telehealth visits in diabetes care during and after the COVID-19 pandemic among adults with type 2 diabetes and their providers: Qualitative study. JMIR Diabetes, 8, e44283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Cannon CA, Ramchandani MS, & Golden MR (2022). Feasibility of a novel self-collection method for blood samples and its acceptability for future home-based PrEP monitoring. BMC Infectious Diseases [Electronic Resource], 22, 459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Knitza J, Tascilar K, Vuillerme N, Eimer E, Matusewicz P, Corte G, Schuster L, Aubourg T, Bendzuck G, Korinth M, Elling-Audersch C, Kleyer A, Boeltz S, Hueber AJ, Krönke G, Schett G, & Simon D (2022). Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients—Results from a randomized controlled trial. Arthritis Research & Therapy, 24, 125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.King ER, Garrett HE, Abernathy H, Cassidy CA, Cabell CR, Shook-Sa BE, Juliano JJ, Boyce RM, Aiello AE, & Ciccone EJ (2023). Comparison of capillary blood self-collection using the Tasso-SST device with venous phlebotomy for anti-SARS-CoV-2 antibody measurement. Journal of Immunological Methods, 520, 113523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hendelman T, Chaudhary A, LeClair AC, van Leuven K, Chee J, Fink SL, Welch EJ, Berthier E, Quist BA, Wald A, Wener MH, Hoofnagle AN, & Morishima C (2021). Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing. PLoS ONE, 16, e0255841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Groenendijk WN, Griffin TP, Islam MN, Blake L, Wall D, Bell M, & O’Shea PM (2022). Remote capillary blood collection for HbA 1c measurement during the COVID-19 pandemic: A laboratory and patient perspective. Diabetic Medicine, 39, e14897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wickremsinhe E, Fantana A, Berthier E, Quist BA, Lopez de Castilla D, Fix C, Chan K, Shi J, Walker MG, Kherani JF, Knoderer H, Regev A, & Harding JJ (2023). Standard venipuncture vs a capillary blood collection device for the prospective determination of abnormal liver chemistry. The Journal of Applied Laboratory Medicine, 8, 535–550. [DOI] [PubMed] [Google Scholar]
- 16.Mbughuni MM, Stevens MA, Langman LJ, Kudva YC, Sanchez W, Dean PG, & Jannetto PJ (2020). Volumetric microsampling of capillary blood spot vs whole blood sampling for therapeutic drug monitoring of tacrolimus and cyclosporin A: Accuracy and patient satisfaction. The Journal of Applied Laboratory Medicine, 5, 516–530. [DOI] [PubMed] [Google Scholar]
- 17.Dewes MM, da Silva LC, Meireles YF, de Freitas MV, Bastiani MF, Lizot LF, Hahn RZ, Antunes MV, & Linden R (2022). Evaluation of the Tasso-SST® capillary blood microsampling device for the measurement of endogenous uracil levels. Clinical Biochemistry, 107, 1–6. [DOI] [PubMed] [Google Scholar]
- 18.Goodrum JM, Lewis LA, Fedoruk MN, Eichner D, & Miller GD (2022). Feasibility of microvolumetric capillary whole blood collections for usage in Athlete Biological Passport analysis. Drug Testing and Analysis, 14, 1291–1299. [DOI] [PubMed] [Google Scholar]
- 19.Lam MP, Ping P, & Murphy E (2016). Proteomics research in cardiovascular medicine and biomarker discovery. Journal of the American College of Cardiology, 68, 2819–2830. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data that supports the findings of this study are available in the supplementary material of this article.
